These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 23975748

  • 1. The CTLA-4 +49GG genotype is associated with susceptibility for nephrotic kidney diseases.
    Spink C, Stege G, Tenbrock K, Harendza S.
    Nephrol Dial Transplant; 2013 Nov; 28(11):2800-5. PubMed ID: 23975748
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
    Mishra OP, Chhabra P, Narayan G, Srivastava P, Prasad R, Singh A, Abhinay A, Batra VV.
    Indian J Pediatr; 2019 Jan; 86(1):26-31. PubMed ID: 29968132
    [Abstract] [Full Text] [Related]

  • 3. CTLA-4 Polymorphisms in Patients with IgA Nephropathy Correlate with Proteinuria.
    Jacob M, Ohl K, Goodarzi T, Harendza S, Eggermann T, Fitzner C, Hilgers RD, Bolte A, Floege J, Rauen T, Tenbrock K.
    Kidney Blood Press Res; 2018 Jan; 43(2):360-366. PubMed ID: 29539619
    [Abstract] [Full Text] [Related]

  • 4. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C, Hou WH, Ding XX, Wang X, Zhao H, Han XW, Wang WJ.
    Asian Pac J Cancer Prev; 2016 Jan; 17(8):3785-91. PubMed ID: 27644617
    [Abstract] [Full Text] [Related]

  • 5. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S, Izadi Jahromi F, Dabbaghmanesh MH, Malekzadeh M, Ghaderi A.
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
    Zhu CL, Huang Q, Liu CH, Xie F.
    Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
    [Abstract] [Full Text] [Related]

  • 7. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
    Gunesacar R, Erken E, Dinkci S.
    Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the transcriptional regulation of the human MT1-MMP gene and association of risk reduction for focal-segmental glomerulosclerosis with two functional promoter SNPs.
    Munkert A, Helmchen U, Kemper MJ, Bubenheim M, Stahl RA, Harendza S.
    Nephrol Dial Transplant; 2009 Mar; 24(3):735-42. PubMed ID: 18927121
    [Abstract] [Full Text] [Related]

  • 9. The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults.
    Jin P, Xiang B, Huang G, Zhou Z.
    J Endocrinol Invest; 2015 Feb; 38(2):149-54. PubMed ID: 25185645
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK, Kapoor R, Pandey SK, Sharma RK, Agrawal S.
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [Abstract] [Full Text] [Related]

  • 14. Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study.
    Wang NG, Wang DC, Tan BY, Wang F, Yuan ZN.
    Int J Clin Exp Pathol; 2015 Mar; 8(6):7421-5. PubMed ID: 26261646
    [Abstract] [Full Text] [Related]

  • 15. -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.
    Oliveira VB, Dezan MR, Gomes FCA, Menosi Gualandro SF, Krieger JE, Pereira AC, Marsiglia JD, Levi JE, Rocha V, Mendrone-Junior A, Sabino EC, Dinardo CL.
    Int J Immunogenet; 2017 Oct; 44(5):219-224. PubMed ID: 28815969
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
    Liang J, Zhang S, Luo Q, Li W, Tian X, Zhang F, Zhao T, Chen X, Zhang X.
    Gene; 2015 Sep 01; 568(2):196-202. PubMed ID: 26013045
    [Abstract] [Full Text] [Related]

  • 18. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E, Frydecka I, Bolanowski M, Tomkiewicz A, Jonkisz A, Karabon L, Partyka A, Nowak O, Szalinski M, Daroszewski J.
    Endocrine; 2017 Jan 01; 55(1):186-199. PubMed ID: 27638540
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
    Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
    Clin Exp Nephrol; 2018 Dec 01; 22(6):1266-1280. PubMed ID: 29679356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.